A Word From The Immediate Past Co-Editors-in-Chief – Goodbye!

Dear Readers,

The past two years have been an exciting opportunity for us as editors and, more recently, as Editors-in-Chief of the Rho Chi Post. Your contributions, comments, and articles have inspired and enabled us to set a high standard for student publication platforms across the nation.

We want to take this opportunity to thank the wonderful fellow classmates and Doctors of the Class of 2013 at St. John’s University College of Pharmacy and Health Sciences. We want to thank Dr. S. William Zito for being extremely supportive of the Rho Chi Post and for being an inspiration to all of us. We are grateful for the faculty members and administrators at the College of Pharmacy and Health Sciences for their continuous support and advice. Last but not least, we want to thank you, our readers, for making this possible. Without your contributions, feedback, and comments, we would not be where we are today. Please continue to be active with the Rho Chi Post, and we hope you will honor the 2013 Editorial Team the same way you have honored us. Once again thank you to everyone and congratulations to PharmD Class of 2013.

Sincerely,
Steve Soman and Neal Shah
Immediate Past Co-Editors-in-Chief

eMAR

Recent Posts

Oxidative Stress and Its Impact on Vitiligo

By: Zurriya Faran, PharmD Candidate c/o 2031 The visible loss of skin pigmentation often indicates…

2 months ago

Thiamine Metabolic Dysfunction Syndrome: Overview, importance, MOA, and treatment

By: Archana Murugan, PharmD candidate c/o 2029 Overview             Thiamine metabolic dysfunction syndrome (TMDS) refers…

2 months ago

Updated Guidelines for the Treatment of Multidrug and Rifampin-Resistant TB and Promising New Anti-TB Drugs in Phase 2/3 Trials

By: Kevin Lee, PharmD Candidate c/o 2028, Angela Yin, PharmD Candidate c/o 2028             The…

2 months ago

Sixth Year Perspective: Interview with Ariella Zadrima, PharmD Candidate, c/o 2026

By: Aymon Choudhury, PharmD Candidate c/o 2027 APPE questions: How did your APPE rotations shape…

2 months ago

Foundayo: The New Drug in the GLP-1 market

By: Sariah Grant, PharmD Candidate c/o 2027             The rise of glucagon-like peptide -1 receptor…

2 months ago

Should All Drugs be OTC? Risks and Consequences of the FDA Commissioner Statement

By: Amanda Kastel, PharmD Candidate c/o 2027 In February 2026, FDA Commissioner Marty Makary stated…

2 months ago